London · Delayed Price · Currency is GBP · Price in GBX Nichols Earnings Call Transcripts
Fiscal Year 2026
-
The acquisition of VITHIT for €75 million strengthens the portfolio in the health and wellness segment, is immediately earnings enhancing, and is expected to deliver strong synergies and long-term shareholder returns. Integration is supported by operational alignment and retention of key management.
-
Strong H1 results with 4.7% revenue growth, record cash generation, and robust international performance, especially in Africa and the Middle East. Margin expansion, disciplined cost control, and a progressive dividend policy support a positive outlook for the full year.
Fiscal Year 2025
-
Delivered 10% operating profit growth and improved margins, supported by strong cash reserves and strategic execution. New product launches and international expansion are planned for 2026, with a higher dividend payout ratio reflecting board confidence.
-
Delivered strong H1 results with 17% Africa revenue growth, 4% adjusted operating profit growth, and robust cash flow. Outlook remains positive with accelerated H2 growth expected from Middle East phasing and ERP benefits.
Fiscal Year 2024
-
Strong packaged revenue and margin growth drove a 15.6% rise in adjusted PBT, with robust performance in both UK and international markets. Strategic investments in marketing, innovation, and supply chain, along with disciplined capital allocation, support ambitious medium-term growth targets.